Development of a deep‐learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2‐low cases

Documenti analoghi

• Practical implementation of AI in a non‐academic, non‐commercial Pathology laboratory: Real world experience and lessons learned
  di: Frederik Deman, et al.
  Pubblicazione: (2025)
• Optimizing breast core needle biopsy biomarker throughput using an AI ‐based workflow
  di: Frederik Deman, et al.
  Pubblicazione: (2026)
• HER2‐positive grade 1 invasive carcinomas of the breast
  di: Andrew H S Lee, et al.
  Pubblicazione: (2024)
• Quantitative comparison of immunohistochemical HER2‐low detection in an interlaboratory study
  di: Maaike Anna Hempenius, et al.
  Pubblicazione: (2024)
• HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls
  di: Huina Zhang, et al.
  Pubblicazione: (2024)